Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2009

View Archived Issues

GPR3 identified as a new pharmacological target for Alzheimer's disease

Coeloglossum viride extract protective in models of brain ischemia

Mechanism of action, activity of the coumarin scopoletin described

Meditor concludes merger agreement with American Medical Technologies

Protalix BioTherapeutics receives research grant from the Israeli government

FDA accepts for review Endo's complete response submission to NDA for Nebido

Novel MC4 receptor agonists prepared and tested at Santhera

Metabolex patents novel glucose-dependent insulinotropic receptor agonists

Janssen Pharmaceutica claims novel cannabinoid modulators

Biothera receives approval to launch two phase II lung cancer trials

Alimera reports 12-month interim safety and efficacy results for Iluvien

ReGen reports first findings from Colostrinin peptide studies

Auris Medical initiates phase IIb AM-101 trial in acute inner ear tinnitus

Novel matrix metalloprotease inhibitor shows efficacy in lung inflammation in vivo

T-115 shows potent antitumor activity in vitro and in vivo

BioCis Pharma commences phase IIa testing for ProtoCure in psoriasis

Dainippon launches Trerief in Japan for Parkinson's disease

Renovo reports phase II results for Juvidex

Oncolytics initiates patient enrollment in phase II trial of Reolysin in NSCLC

Vertex Pharmaceuticals acquires ViroChem Pharma

Nippon Chemiphar presents novel P2X4 receptor antagonists

Yakult Honsha claims novel gamma-secretase inhibitors

Edluar receives FDA approval for insomnia

Medivir: fourth quarter in brief

YM BioSciences enrolls first patient into multinational nimotuzumab trial in NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...